Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants [Phase 3]
Phase 3 trial evaluating the immunogenicity and reactogenicity of GSK DTPa-HBV-IPV and Hib vaccines when coadministered to healthy infants.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. [Phase 4]
This Phase 4 trial update evaluates immunogenicity, antibody persistence, and safety of GSK's DTPa INFANRIX and dTpa BOOSTRIX vaccines; the …
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]
Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent va…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]
Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed s…
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers [Phase 3]
A Phase 3 trial comparing Pediacel to Infanrix-IPV+Hib when co-administered with Prevenar in infants and toddlers has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Study of Adacel® Vaccine Administered to Persons 10 Years of Age [Phase 4]
Phase 4 clinical trial of the Adacel vaccine in 10-year-olds with results posted, evaluating safety and immunogenicity against tetanus, diph…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels [Phase 4]
A Phase 4 study evaluating tetanus immunization in individuals with no immunization history or sub-protective antibody levels was terminated…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age [Phase 4]
Phase 4 clinical trial update on Menactra in healthy infants at 9 months and co-administered with Pentacel at 15-18 months; results have bee…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Duration of Protection: GSK DTaP Vaccines
A completed clinical trial from GlaxoSmithKline evaluated the duration of protection provided by GSK's DTaP vaccine against diphtheria, teta…
-
CLINICAL_TRIALS withdrawal · 2015-10-09Clinical Trial Update: A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) [Phase 3]
A Phase 3 study evaluating immunogenicity and safety of a whole-cell pertussis–containing vaccine given with Rotarix or RotaTeq has been wit…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years Old [Phase 3]
Phase 3 trial comparing intramuscular SP306 to subcutaneous DT in Japanese adolescents aged 11-12 evaluating vaccines for tetanus, diphtheri…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) [Phase 3]
Phase 3 trial of an investigational V441-001 vaccine in healthy infants in Taiwan has completed, targeting diphtheria, tetanus, pertussis, h…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth [Phase 3]
Phase 3 trial of the DTaP-IPV-HepB-PRP-T pentavalent vaccine in Indian infants completed; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Database Surveillance Safety Study of PENTACEL® Vaccine
Completed database surveillance safety study evaluating the Pentacel vaccine for safety signals related to its diphtheria, tetanus, pertussi…
-
CLINICAL_TRIALS research · 2015-08-07Clinical Trial Update: Khushi Baby (KB): Novel Mobile Health Solution for Vaccination Record Keeping in India [NA]
A clinical trial update notes the Khushi Baby mobile health solution for vaccination record keeping in India, focusing on the DTP vaccine se…
-
CLINICAL_TRIALS research · 2015-07-28Clinical Trial Update: Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates [Phase 4]
Phase 4 clinical trial update from a French hospital on an immunisation schedule combining diphtheria, tetanus, poliomyelitis with Pertussis…
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants
GlaxoSmithKline-sponsored trial examining risk factors for pertussis infection among infants has completed.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age [Phase 3]
A Phase 3 trial evaluating the DTap-IPV vaccine as the fifth dose in children aged 4 to 6 years, comparing it with DAPTACEL and IPOL; result…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
Follow-up study reports antibody responses to hepatitis B, acellular pertussis toxin, and inactivated poliovirus antigens 1 month after the …
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China. [Phase 3]
Phase 3 trial in China evaluating Sanofi Pasteur's Tdap booster vaccine against local diphtheria-tetanus vaccines in children and adolescent…
-
CLINICAL_TRIALS research · 2015-05-04Clinical Trial Update: Comparison of Immunization Quality Improvement Dissemination Study [NA]
This is a completed clinical trial examining a immunization quality improvement dissemination study sponsored by Children's National Researc…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated Poliomyelitis [Phase 2]
Phase 2 trial of a combined tetanus, diphtheria, acellular pertussis, and inactivated poliomyelitis vaccine sponsored by Sanofi Pasteur has …
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants [Phase 3]
Phase 3 trial comparing the safety and immunogenicity of Pediacel versus Infanrix IPV+Hib (Penta) given in a 3-dose schedule in infants; the…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]
Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has com…